Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Intervening in beta-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis
  2. Stein, U.; Arlt, F.; Smith, J.; Sack, U.; Herrmann, P.; Walther, W.; Lemm, M.; Fichtner, I.; Shoemaker, R. H.; Schlag, P. M.
  3. Neoplasia. 2011, Feb; 13(2): 131-144.
  1. 2.   JS-K; a nitric oxide-releasing prodrug, modulates beta-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism
  2. Nath, N.; Chattopadhyay, M.; Pospishi, L.; Cieciura, L. Z.; Goswami, S.; Kodela, R.; Saavedra, J. E.; Keefer, L. K.; Kashfi, K.
  3. Biochemical Pharmacology. 2010, Dec; 80(11): 1641-1649.
  1. 3.   Proline oxidase, a p53-induced gene, targets COX-2/PGE(2) signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Phang, J. M.
  3. Oncogene. 2008 27(53): 6729-6737.
  1. 4.   Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid
  2. Isenberg, J. S.; Jia, Y.; Field, L.; Ridnour, L. A.; Sparatore, A.; Del Soldato, P.; Sowers, A. L.; Yeh, G. C.; Moody, T. W.; Wink, D. A.; Ramchandran, R.; Roberts, D. D.
  3. British Journal of Pharmacology. 2007, May; 151(1): 142-151.
  1. 5.   Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines
  2. Romanowska, M.; Kikawa, K. D.; Fields, J. R.; Maciag, A.; North, S. L.; Shiao, Y. H.; Kasprzak, K. S.; Anderson, L. M.
  3. Lung Cancer. 2007, Jan; 55(1): 35-42.
  1. 6.   Natural inhibitors of carcinogenesis
  2. Kinghorn, A. D.; Su, B. N.; Jang, D. S.; Chang, L. C.; Lee, D.; Gu, J. Q.; Carcache-Blanco, E. J.; Powlus, A. D.; Lee, S. K.; Park, E. J.; Cuendet, M.; Gills, J. J.; Bhat, K.; Park, H. S.; Mata-Greenwood, E.; Song, L. L.; Jong, M. H.; Pezzuto, J. M.
  3. Planta Medica. 2004, AUG; 70(8): 691-705.
  1. 7.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 8.   A systems modeling approach to the study of retinoid function: Implications for evaluation of retinoids in cancer chemoprevention and/or chemotherapy
  2. Lewis, K. C.; Hochadel, J. F.; Zech, L. A.
  3. Mathematical Modeling in Nutrition and the Health Sciences. 2003; 537 : 301-316.
  1. 9.   Dehydroepiandrosterone inhibits the expression of carcinogen- activating enzymes in vivo
  2. Ciolino, H.; MacDonald, C.; Memon, O.; Dankwah, M.; Yeh, G. C.
  3. International Journal of Cancer. 2003 105(3): 321-325.
  1. 10.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 11.   Inhibition of carcinogen-activating enzymes by 16 alpha-fluoro- 5-androsten-17-one
  2. Ciolino, H. P.; MacDonald, C. J.; Yeh, G. C.
  3. Cancer Research. 2002 62(13): 3685-3690.
  1. 12.   Modulation of cyclophilin gene expression by N-4- (hydroxyphenyl)retinamide: Association with reactive oxygen species generation and apoptosis
  2. Hursting, S. D.; Shen, J. C.; Sun, X. Y.; Wang, T. T. Y.; Phang, J. M.; Perkins, S. N.
  3. Molecular Carcinogenesis. 2002 33(1): 16-24.
  1. 13.   2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice
  2. Green, J. E.; Shibata, M. A.; Shibata, E.; Moon, R. C.; Anver, M. R.; Kelloff, G.; Lubet, R.
  3. Cancer Research. 2001 61(20): 7449-7455.
  1. 14.   Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially
  2. Ciolino, H. P.; Daschner, P. J.; Yeh, G. C.
  3. Biochemical Journal. 1999 340(Part 3): 715-722.
  1. 15.   The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
  2. Ciolino, H. P.; Yeh, G. C.
  3. British Journal of Cancer. 1999 79(9-10): 1340-1346.
  1. 16.   Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis
  2. Shen, J. C.; Wang, T. T. Y.; Chang, S.; Hursting, S. D.
  3. Molecular Carcinogenesis. 1999 24(3): 160-168.
  1. 17.   Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice
  2. Ward, J. M.; Tadesse-Heath, L.; Perkins, S. N.; Chattopadhyay, S. K.; Hursting, S. D.; Morse, H. C.
  3. Laboratory Investigation. 1999 79(1): 3-14.
  1. 18.   Effects of Dehydroepiandrosterone and Calorie Restriction On the Bcl-2/Bax-Mediated Apoptotic Pathway in P53-Deficient Mice
  2. Wang, T. T. Y.; Hursting, S. D.; Perkins, S. N.; Phang, J. M.
  3. Cancer Letters. 1997 116(1): 61-69.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel